Benefit-risk assessment: to quantify or not to quantify, that is the question

Pharmacoepidemiol Drug Saf. 2011 Jun;20(6):653-6. doi: 10.1002/pds.2149.
No abstract available

MeSH terms

  • Clinical Trials as Topic / methods
  • Drug Approval / organization & administration*
  • Drug Design*
  • Drug Discovery / economics
  • Drug Discovery / methods
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Pharmaceutical Preparations / administration & dosage
  • Pharmaceutical Preparations / economics
  • Research Design

Substances

  • Pharmaceutical Preparations